AmolRajeevRaoMD

M.D.

Dr. Rao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2013 - 2014
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2012 - 2013
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2011 - 2012
SUNY Health Science Center at BrooklynResidency, Internal Medicine, 2007 - 2010
St. George's University School of MedicineClass of 2007

ASCO Survey on COVID-19 in Oncology (ASCO) Registry Start of enrollment: 2020 Apr 19
Active, not recruiting
Roles: Contact

PubMed

33 citations
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer
Tanya B. Dorff, Jeff Longmate, Sumanta K. Pal, Walter M. Stadler, Mayer Fishman, Ulka N. Vaishampayan, Amol Rao, Jacek K. Pinksi, James S. Hu, David I. Quinn, Primo N....> ;Cancer. 2017 Aug 22
17 citations
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function
Deborah J.L. Wong, Amol . Rao, Earl Avramis, Douglas Matsunaga, Kimberly Komatsubara, Mohammad Atefi, Helena Escuin-Ordinas, Thinle Chodon, Richard C. Koya, Antoni Rib...> ;Cancer Immunology Research. 2014 Jan 30